lansoprazole and c-peptide

lansoprazole has been researched along with c-peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gao, Y; Hao, S; Sun, J; Sun, X; Tian, X; Zhang, Z1
Attri, SV; Dayal, D; Gupta, VK; Reddy, R; Sachdeva, N1

Other Studies

2 other study(ies) available for lansoprazole and c-peptide

ArticleYear
Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjects.
    The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:8

    Topics: Adult; Animals; Area Under Curve; Blood Glucose; C-Peptide; Diet; Drug Synergism; Drug Therapy, Combination; Glucose; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Pyrazines; Sitagliptin Phosphate; Triazoles

2014
Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study.
    Einstein (Sao Paulo, Brazil), 2022, Volume: 20

    Topics: Blood Glucose; C-Peptide; Child; Cholecalciferol; Diabetes Mellitus, Type 1; Disease Progression; Humans; Insulin; Lansoprazole; Pilot Projects

2022